These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34970555)

  • 1. Editorial: A Compendium of Recent Research on Stem Cell-Based Therapy for Covid-19.
    Hmadcha A; Soria B; Zhao RC; Smani T; Valverde I
    Front Cell Dev Biol; 2021; 9():813384. PubMed ID: 34970555
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.
    Pensato U; Muccioli L; Cani I; Janigro D; Zinzani PL; Guarino M; Cortelli P; Bisulli F
    Ann Clin Transl Neurol; 2021 Apr; 8(4):968-979. PubMed ID: 33780166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Transplantation Therapy: A Potential Method for Treating Cytokine Storm Syndromes Induced by COVID-19.
    Wang HC; Wang X; Long X
    Cell Transplant; 2020; 29():963689720965980. PubMed ID: 33040594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
    Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
    World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review.
    Adugna DG
    Stem Cells Cloning; 2021; 14():71-80. PubMed ID: 34785907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
    Cai Q; Yin F; Hao L; Jiang W
    Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19.
    Kheirkhah AH; Shahcheraghi SH; Lotfi M; Lotfi M; Raeisi S; Mirani Z
    Protein Pept Lett; 2021; 28(8):945-952. PubMed ID: 33618635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2.
    Nazerian Y; Vakili K; Ebrahimi A; Niknejad H
    Front Cell Dev Biol; 2021; 9():717587. PubMed ID: 34540833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence.
    Kiaie N; Ghanavati SPM; Miremadi SS; Hadipour A; Aghdam RM
    Int J Stem Cells; 2021 Aug; 14(3):252-261. PubMed ID: 34158414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
    Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
    Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).
    Wang X; He Z; Zhao X
    Exp Ther Med; 2021 Apr; 21(4):319. PubMed ID: 33732292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6: from arthritis to CAR-T-cell therapy and COVID-19.
    Kishimoto T
    Int Immunol; 2021 Sep; 33(10):515-519. PubMed ID: 33715009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19.
    Gupta A; Shivaji K; Kadam S; Gupta M; Rodriguez HC; Potty AG; El-Amin SF; Maffulli N
    Expert Opin Biol Ther; 2021 Dec; 21(12):1551-1560. PubMed ID: 33886388
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.